Gastric Bypass Surgery: Clinical Trials

14 trials for Gastric Bypass Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 unknown, 2 withdrawn. 5 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Recruiting 2
Phase 22Not yet recruiting 1, Unknown 1
Phase 11Terminated 1
Phase 31Unknown 1

Follow Gastric Bypass Surgery: new trials by email Literature Review of Gastric Bypass Surgery trials Research Report on Gastric Bypass Surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease
Anakinra (interleukin-1 receptor antagonist), Placebo Comparator (0.9% NaCl) - Postprandial Hypoglycemia, End-stage Renal Disease (ESRD)
Phase 2Not yet recruitingMarc Donath12026-07-012026-05-12
Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study
Gastric Bypass Surgery, Revisional Bariatric Surgery
Active not recruitingVrinnevi Hospital1992025-11-012026-01-20
Efficacy of Oversewing Versus Surgical Ligation Clips for Staple Line Reinforcement of the Gastric Pouch to Reduce Post Operative Bleeding in Laparoscopic One Anastomosis Gastric Bypass
Oversewing, Surgical Ligation Clips - Gastric Bypass Surgery
Not applicableRecruitingCairo University302025-05-182025-11-20
Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA
Bariatric surgery (Sleeve Gastrectomy or Gastric Bypass) - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis
RecruitingHospices Civils de Lyon202025-04-152026-01-15
Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery
Continuous glucose monitor (Dexcom® G7) - Hypoglycemia Non-Diabetic, Gastric Bypass Surgery
Not applicableRecruitingSykehuset i Vestfold HF1002024-11-122024-11-05
A Comparative Study Between Effect Of Mini-gastric Bypass and Single Anastmosis Sleeve Jujenal Bypass On Levels Of GLP-1, GIP, PYY, Insulin Resistance and Type II DM Resolution
Single anastomosis sleeve jejunal bypass, One anastomosis gastric bypass - Incretin Hormones Plasma Levels, Gastric Bypass Surgery
Not applicableCompletedAin Shams University402024-02-012026-03-16
Ex Vivo Evaluation of Laser Induced Thermal Tissue Damage
Non-ionising radiation - Gastric Bypass Surgery
Not applicableCompletedRSP Systems A/S22019-01-012019-07-02
Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans
Ursodeoxycholic Acid, Placebos - Glucose Intolerance, Gastric Bypass Surgery
Phase 1TerminatedVanderbilt University Medical Center22018-02-012021-04-20
The Effect of Roux-en-Y Gastric Bypass on Bone Turnover
Roux-en-Y gastric bypass - Gastric Bypass Surgery, Obesity
UnknownHvidovre University Hospital202015-09-012017-02-08
The Effects of Probiotic Supplementation on the Results of Gastric Bypass Surgery
probiotic, Placebo - Gastric Bypass Surgery
Phase 2 / Phase 3UnknownNational Nutrition and Food Technology Institute502015-09-012016-03-15
Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery
Liquid Meal, Solid Meal - Gastric Bypass Surgery, Obesity
Not applicableCompletedSt. Luke's-Roosevelt Hospital Center332010-09-012016-12-29
Energy Expenditure and Gastric Bypass Surgery
Gastric Bypass Surgery
WithdrawnMayo Clinic2009-10-012015-02-12
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
Gastric Bypass Surgery, Gastric Banding
WithdrawnSt. Luke's-Roosevelt Hospital Center2008-09-012015-09-11
Mechanisms of Diabetes Control After Weight Loss Surgery
gastric bypass surgery, Diet induced weight loss - Gastric Bypass Surgery, Obesity
CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)202005-09-012018-03-09

Narrower conditions

Obesity (3)  ·  Diabetes Mellitus (2)  ·  Bone Diseases, Metabolic (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Glucose Metabolism Disorders (1)  ·  Hypoglycemia (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Kidney Failure, Chronic (1)  ·  Liver Cirrhosis (1)

Broader conditions

Nutritional and Metabolic Diseases (7)  ·  Metabolic Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Glucose Metabolism Disorders (4)  ·  Body Weight (3)  ·  Endocrine System Diseases (3)  ·  Nutrition Disorders (3)  ·  Overnutrition (3)  ·  Overweight (3)  ·  Signs and Symptoms (3)  ·  Pathologic Processes (2)  ·  Bone Diseases (1)  ·  Chronic Disease (1)  ·  Diabetes Mellitus (1)  ·  Digestive System Diseases (1)

Interventions

Gastric Bypass (2)  ·  Bariatric Surgery (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Probiotics (1)  ·  Radiation, Nonionizing (1)  ·  Receptors, Interleukin-6 (1)  ·  Sodium Chloride (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

St. Luke's-Roosevelt Hospital Center (2)  ·  Ain Shams University (1)  ·  Cairo University (1)  ·  Hospices Civils de Lyon (1)  ·  Hvidovre University Hospital (1)  ·  Marc Donath (1)  ·  Mayo Clinic (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  National Nutrition and Food Technology Institute (1)  ·  RSP Systems A/S (1)  ·  Sykehuset i Vestfold HF (1)  ·  Vanderbilt University Medical Center (1)  ·  Vrinnevi Hospital (1)

Countries

United States (4)  ·  Denmark (2)  ·  Egypt (2)  ·  France (1)  ·  Iran (1)  ·  Norway (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Blandine Laferrere, MD (3)  ·  Ellen A Andersson, MD (1)  ·  George AbdElFady Nashed Aiad, M.D (1)  ·  Matthias Hepprich, PD Dr. med. (1)  ·  Mohey Eldin R ElBanna, Professor of General Surgery (1)  ·  Naji Abumrad, MD (1)

Results publications

PMID 17416796, PMID 20501690, PMID 24296713, PMID 29725975, PMID 30612325

NIH funding

2025 (1), R01DK067561 (1), R01DK072479 (1)